The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 13 of the 56 sources its claims cite were checked for support.
Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial
Open accessAbstract
Background/AimsThe relation between heart rate variability (HRV) as non-invasive biomarkers of autonomic function and cognitive behavior therapy (CBT) as non-pharmacological treatments has rarely been examined in patients with constipation-predominant irritable bowel syndrome (IBS-C).The purpose of this study is to evaluate the efficacy of an 8-week CBT intervention on HRV and IBS symptoms, and the correlation of changes in HRV with changes in IBS symptoms among young female nursing students with IBS-C. MethodsThis study consisted of an exploratory subgroup analysis of 43 participants with IBS-C who had been randomly assigned to receive either 8 weeks of CBT (n = 23) or general medical information (control, n = 20).At baseline and 8, 16, and 24 weeks, participants completed a questionnaire assessing their gastrointestinal (GI) symptoms, anxiety, depression, and stress, and their HRV was measured via electrocardiography. ResultsAt the 8-week follow-up, the high-frequency (HF) power was significantly higher, and the low-frequency (LF)/HF ratio was lower in the CBT group than in the control group (P < 0.001 for both), and the severity of GI symptoms (P = 0.003), anxiety (P < 0.001), depression (P < 0.001), and stress (P < 0.001) was significantly lower in the CBT group than in the control group.Changes in the HF power were significantly and inversely associated with changes in GI symptoms, anxiety, depression, and stress at 16 and 24 weeks (P < 0.05 for all; range of r from -0.37 to -0.68).Changes in the LF/HF ratio were also significantly and positively associated with changes in GI symptoms, anxiety, depression, and stress at 16 and 24 weeks (P < 0.05 for all; range of r from 0.38 to 0.60). ConclusionsCBT was effective in managing symptoms in young IBS-C patients and the improvement of symptoms was sustained at 24 weeks following the completion of CBT.Furthermore, indirect measurement of autonomic function using HRV may be a useful objective parameter for assessing response to CBT in young IBS-C patients.(
Overview
CoChat Summary
TL;DR
In an exploratory subgroup analysis of 43 young female nursing students with constipation-predominant IBS, 8 weeks of cognitive behavior therapy increased high-frequency HRV power and decreased the LF/HF ratio while reducing GI symptoms, anxiety, depression, and stress versus control. These improvements were sustained through 24 weeks, and changes in HRV correlated with changes in symptoms.
Key findings
- At 8 weeks, HF power was significantly higher and the LF/HF ratio significantly lower in the CBT group than in the control group (P < 0.001 for both); GI symptom severity (P = 0.003), anxiety (P < 0.001), depression (P < 0.001), and stress (P < 0.001) were also significantly lower with CBT.
- Group × time interactions were significant for HF and LF/HF ratio (P < 0.001 for both), with significant between-group contrasts at 8, 16, and 24 weeks for HF (P = 0.017, P = 0.001, P < 0.001) and LF/HF ratio (P = 0.003, P < 0.001, P < 0.001).
- Changes in HF power were inversely associated with changes in GI symptoms, anxiety, depression, and stress at 16 and 24 weeks (P < 0.05 for all; r = −0.37 to −0.68); changes in LF/HF ratio were positively associated with the same outcomes (P < 0.05 for all; r = 0.38 to 0.60). At 8 weeks, LF/HF change was significantly associated only with depression change (r = 0.44, P < 0.01).
Methods
- Exploratory subgroup analysis of a randomized controlled trial; 43 female nursing students with IBS-C diagnosed by Rome III were randomized to 8-week CBT (n = 23) or general medical information control (n = 20), with assessments at baseline and 8, 16, and 24 weeks.
- CBT consisted of 8 weekly group sessions of 80 minutes (60 minutes thematic training, 20 minutes relaxation training); controls received general IBS information and usual care for 50 minutes in the first week.
- HRV was measured by ECG with frequency-domain analysis of HF (0.15–0.4 Hz) and LF (0.04–0.15 Hz) and the LF/HF ratio; outcomes included GSRS-IBS for GI symptoms, HADS for anxiety/depression, and GARS for stress, analyzed with linear mixed effects models and Pearson correlations.
Limitations
- The paper states possible placebo effect/treatment bias because participants may have known their group assignment, no healthy comparison group, all participants were female so findings may not apply to males or middle-aged/older populations, only IBS-C was studied, and GI symptoms were not severe by Rome III criteria.
- The paper also notes the need for larger samples and participants with more severe GI symptoms; this was an exploratory subgroup analysis with n = 43 and 38 completers, and estimated power for the two primary HRV outcomes ranged from 0.57 to 0.98.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
6 Valid · 4 Not valid · 22 Not checked · 58 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“The mechanism by which CBT improves somatic symptoms is related to the regulation of brain-gut axis function.15,22,24”
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Introduction
What the sources say
- Disputedcites [15] sourceExperimental — accuracy not yet measured
Our copy of Deechakawan et al. (2013) never proposes a brain-gut regulatory mechanism for CBT's benefit; the Abstract states that despite marked improvements in reported stress and previously reported GI and psychological distress symptoms, the cognitively based CSM program did not reduce urine cortisol, and that 'less is known about the physiological impact of such a change'. The Discussion reinforces this, reporting Heymann-Monnikes' CBT trial showed 'improvements in subjective but not a physiologic measure' and suggesting current biomarkers of visceral sensitivity and overnight cortisol 'may not be sensitive enough', while also cautioning that 'the link between stress and abdominal symptoms in IBS may not be as straightforward as originally thought'. Brain-gut/HPA material appears only as background pathophysiology (central processing of GI afferents; HPA dysregulation in some IBS patients), credited to Mulak & Bonaz 2004 and Chang et al. 2009/Dinan et al. 2006, not as the intervention's mechanism. (LLM, conf=0.62)
Checked by a reasoning model — may be wrong.
- Not checked yetcites [22] source
- Not checked yetcites [24] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Third, all participants were females to control for sex-based differences in coping styles, levels of somatic and psychological symptoms, and physiological responses.8,9,15”
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Discussion
What the sources say
- Partly supportedcites [8] Si, JM, Wang, LJ, Chen, SJ, Sun, LM, and Dai, N (2004). Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol. 10, 1059-1064. sourceExperimental — accuracy not yet measured
Our copy of Si et al. (2004) supports sex-based differences in somatic/extra-colonic symptoms: the Results (p. 1060) report that abdominal pain duration >=1 h/d, headache and poor appetite were more common in female IBS consulters while dysuria was more common in males, and the Discussion notes 'an increased prevalence of extra-colonic symptoms ... in female IBS patients', plus a gender split across bowel-habit subgroups (more IBS-C/IBS-A in women). It does not address coping styles at all (searched: coping style, coping strategy — no passage), and it reports anxiety/depression only for the whole sample and by subgroup, not as a sex difference in psychological symptom levels (Table 4 gives SF-36 by gender against gender-specific norms, not a male-vs-female psychological contrast). The 'physiological responses' element appears only as a hedged remark ('Several physiological factors may play a role in these gender-related differences ... including difference in central autonomic control, enteric nervous system physiology, and smooth muscle physiology') credited in our copy to Lee et al. 2001 (Am J Gastroenterol 96: 2184-2193, their ref 28), so stating it as established sex-based physiological difference overstates the source. Separately, this source's own sample was mixed-sex (312 male, 350 female of 662), so it cannot ground an all-female design claim itself. (LLM, conf=0.72)
- Not checked yetcites [9] source
- Disputedcites [15] sourceExperimental — accuracy not yet measured
Our copy directly contradicts the claim: the Sample Description (Results) reports 143 women AND 31 men providing cortisol data at baseline (90 women and 15 men post-intervention), and the Materials and Methods state aims 2 and 3 explicitly explored and tested gender differences in cortisol/stress between women and men. The Discussion even notes that 'no studies could be found which examined the impact of a behavioral intervention... in women and men with IBS,' positioning this study as one that included both sexes. The paper mentions coping-style/symptom differences between men and women (Hungin et al., 2005) as an explanation for observed gender effects, not as a reason for restricting enrollment to females. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Non-pharmacologic treatments, such as cognitive behavior therapy (CBT), have been effective in improving somatic symptoms of IBS.15,22,23”
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Introduction
What the sources say
- Partly supportedcites [15] sourceExperimental — accuracy not yet measured
Our copy clearly supports the general background point: the Abstract states that 'self-management programs that include cognitive behavioral strategies have been shown to improve gastrointestinal symptoms, psychological distress, and quality of life in persons with irritable bowel syndrome,' and the Introduction (Interventions for IBS) repeats that 'several nonpharmacological intervention studies have been found to improve GI symptoms, psychological distress and QoL in patients with IBS.' However, the outcome attributed in the claim is 'somatic symptoms,' which this paper does not report as an intervention effect — its own trial measured urinary cortisol and diary-rated daily stress (CSM lowered daily stress but not cortisol), and the GI/somatic benefit is credited to other trials (Heitkemper et al. 2004; Jarrett et al. 2009; Drossman et al. 2003; Lackner et al. 2010; Whitehead et al. 2004). The only mentions of 'somatic symptoms' in our copy are titles/context unrelated to treatment response (Cain et al. 2009 reference; Discussion p. on gender differences citing Hungin et al. 2005). So the CBT/non-pharmacologic efficacy part is supported, the 'somatic symptoms' specification is not. (LLM, conf=0.72)
- Not checked yetcites [22] source
- Supportedcites [23] source
The Introduction states that 'increasing researches support behavioral and psychological therapies for IBS symptom management' and that cognitively-focused therapies such as CBT 'do better (ie, reduced gastrointestinal [GI] symptom distress, enhanced quality of life [QOL]) than usual care or wait-list control groups'. The Results section 'Efficacy of Comprehensive Self-management Intervention' and the Abstract (Results) report the nurse-delivered cognitively-focused CSM intervention was more effective than usual care in reducing abdominal pain and GI Symptom score, with strong effects also for bloating/intestinal gas, constipation and urgency (Discussion) — i.e., the somatic IBS symptoms. The paper's hedged Conclusion (about higher sympathetic tone predicting less benefit) qualifies who benefits, not the overall effectiveness claim. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Moreover, sustained effects of CBT have not been adequately tested in IBS patients.23”
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Introduction
What the sources say
- Could not verifycites [23] sourceExperimental — accuracy not yet measured
The Introduction discusses evidence for CBT in IBS but does not assess whether its sustained effects have been adequately tested. The Trial Design and Results describe follow-up at three and six months for a CBT-containing self-management intervention, but they do not make the broader claim about the adequacy of sustained-effect testing. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Participants were included if they were diagnosed as IBS-C by a gastroenterologist based on the questionnaire according to the Rome III criteria.25”
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Materials and Methods > Participants
What the sources say
- Partly supportedcites [25] sourceExperimental — accuracy not yet measured
Our copy clearly supports the questionnaire-based Rome III IBS-C part of the sentence: the 'Rome III questionnaire' section states 'Diagnosis of IBS was based on the presence of abdominal pain or discomfort for at least 3 months in the previous 6 months, with 2 or more of the following symptoms...' and 'We subtyped IBS by using questions in a text form on hard or lumpy stools and loose or watery stools', and Table 4 reports 26 patients subtyped as IBS-C by that questionnaire. What our copy does not support is the qualifier that the IBS-C diagnosis was made 'by a gastroenterologist': in Park et al. the classification rests on patients' self-completed Rome III questionnaires, with physicians' physical examination, blood/urine tests and esophago-gastro-duodenoscopy used only to exclude organic disease and to exclude abnormal results (Study Subjects); gastroenterology experts are mentioned only for feedback on the Korean translation of the questionnaire. So the instrument/criteria identification holds, but the clinician-adjudicated diagnosis is not this source's stated procedure. (LLM, conf=0.68)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
41 more claims · 3 with their cited sources checked
Create a free account to see all 90 claims and to verify the 43 references still open.
- Probably not a substantial claim. 30
- It may state two separate claims as one. 21
- Borderline: one of the tests for a substantial claim is unclear. 1
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only a limited number of clinical trials in IBS have evaluated associations between improvements in the disease course and changes in HRV outcomes, with conflicting results; no such trials have been conducted for IBD (67,68).”
From Alterations in Heart Rate Variability Associated With Irritable Bowel Syndrome or Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis (2021) · cites this paper as [68]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Abstract > Conclusions
“the improvement of symptoms was sustained at 24 weeks following the completion of CBT.”
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Materials and Methods > Study Design
“Data were collected 4 times from both the CBT and control groups: prior to CBT (baseline) and after 8, 16, and 24 weeks.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Abstract > Results
“At the 8-week follow-up, the high-frequency (HF) power was significantly higher, and the low-frequency (LF)/HF ratio was lower in the CBT group than in the control group (P < 0.001 for both)”
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Results > High-frequency and Low-frequency/High-frequency Ratio Responses to Cognitive Behavior Therapy
“LF/HF ratio (P = 0.003 at 8 weeks and P < 0.001 at 16 and 24 weeks)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Abstract > Results
“the severity of GI symptoms (P = 0.003), anxiety (P < 0.001), depression (P < 0.001), and stress (P < 0.001) was significantly lower in the CBT group than in the control group.”
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Results > Gastrointestinal Symptoms, Anxiety, Depression, and Stress Responses to Cognitive Behavior Therapy
“GI symptoms, anxiety, depression, and stress were significantly different between the CBT and control groups at each follow-up (P < 0.001 at 8, 16, and 24 weeks).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Abstract > Results
“At the 8-week follow-up, the high-frequency (HF) power was significantly higher, and the low-frequency (LF)/HF ratio was lower in the CBT group than in the control group (P < 0.001 for both)”
§ Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial > Results > High-frequency and Low-frequency/High-frequency Ratio Responses to Cognitive Behavior Therapy
“HF (P = 0.017 at 8 weeks, P = 0.001 at 16 weeks, and P < 0.001 at 24 weeks)”
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Statistical power analyses using G∗Power 3.1: tests for correlation and regression analyses
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009) · Behavior Research Methods · doi:10.3758/brm.41.4.1149 · Cited by 37,615 · cited 1×
“2 for repeated-measures analysis of variance and with an assumption of 10% attrition.(26) For this subgroup analysis of participants with IBS-C (n = 43), we estimated that power would range from 0.”
MethodDepression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Heart rate variability: origins, methods, and interpretive caveats
BERNTSON, G. G., THOMAS BIGGER, J., ECKBERG, D. L., GROSSMAN, P., KAUFMANN, P. G., MALIK, M., NAGARAJA, H. N., PORGES, S. W., SAUL, J. P., STONE, P. H., et al. (1997) · Psychophysiology · doi:10.1111/j.1469-8986.1997.tb02140.x · Cited by 3,962 · cited 2×
“3 July, 2017 (435-445) the ratio of the LF and HF components, the LF/HF ratio, typically represents an index of sympathetic-to-parasympathetic balance, with higher values indicating greater sympathetic dominance.(27,28)”
BackgroundMethodCardiovascular neural regulation explored in the frequency domain.
Malliani, A., Pagani, M., Lombardi, F., & Cerutti, S. (1991) · Circulation · doi:10.1161/01.cir.84.2.482 · Cited by 3,569
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Psychosocial Aspects of the Functional Gastrointestinal Disorders
Levy, R. L., Olden, K. W., Naliboff, B. D., Bradley, L. A., Francisconi, C., Drossman, D. A., & Creed, F. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.057 · Cited by 776
An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome
American College of Gastroenterology IBS Task Force (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.122 · Cited by 694
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Saha, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6759 · Cited by 500 · cited 2×
“Low vagal activity may be associated with increased norepinephrine levels,(36) heightened esophageal acid sensitivity,(21) blockage of acetylcholine from enteric nerves,(5) reduced release of serotonin in plasma in the enterochromaffin cells,(37) visceral hypersensitivity,(5,36) inhibitory motor neurons in the GI trac…”
BackgroundResultHeart rate variability, trait anxiety, and perceived stress among physically fit men and women
Dishman, R. K., Nakamura, Y., Garcia, M. E., Thompson, R. W., Dunn, A. L., & Blair, S. N. (2000) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(00)00085-4 · Cited by 487
Cited by
Kolacz, J., Kovacic, K. K., & Porges, S. W. (2019) · Developmental Psychobiology · doi:10.1002/dev.21852 · Cited by 94
Ali, M. K., & Chen, J. D. Z. (2023) · Diagnostics · doi:10.3390/diagnostics13020293 · Cited by 98
“, HRV parameters could be used to study the effect of cognitive therapies for IBS [15].”
MethodKoenig, J. (2020) · Psychophysiology · doi:10.1111/psyp.13568 · Cited by 51
Antidepressants for irritable bowel syndrome—A systematic review
Kułak-Bejda, A., Bejda, G., & Waszkiewicz, N. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.05.014 · Cited by 59
Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D
Barbalho, S. M., Goulart, R. D. Á., Araújo, A. C., Guiguer, É. L., & Bechara, M. D. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1570137 · Cited by 51
Metadata
- Authors
- Jang, A., Hwang, S.-K., Padhye, N. S., & Meininger, J. C.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Pusan National University (KR)
- Corresponding author
- Hwang, Sun-Kyung
- Venue
- Journal of Neurogastroenterology and Motility
- Published
- 2017-07-30
- Volume
- 23
- Issue
- 3
- Pages
- 435-445
- ISSN
- 2093-0879 (ISSN-L)
- 2093-0887
- PMC
- PMC5503294
- OpenAlex
- W2612541475
- Semantic Scholar
- 93b372333831bd3cb0de11f79589bb277492bc39
- Cited by
- 35
- References
- 52
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 7 · 2022: 5 · 2020: 5 · 2019: 10 · 2018: 2 · 2017: 2
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of Neurogastroenterology and Motility (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Keywords
- cognitive behavioral therapy, irritable bowel syndrome with constipation, heart rate variability, autonomic function, young women, nursing students, gastrointestinal symptoms, anxiety, depression, stress, non-pharmacological treatment, LF/HF ratio, treatment response biomarkers, psychotherapy efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial. https://app.cochat.ai/papers/10.5056/jnm17017
- The paper
- Jang, A., Hwang, S.-K., Padhye, N. S., & Meininger, J. C. (2017). Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial. Journal of Neurogastroenterology and Motility. https://doi.org/10.5056/jnm17017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.